Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Mauss

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Alimentary Pharmacology & Therapeutics|February 14, 2025
Editorial: The Relevance of Hepatic Flares and Quantitative Hepatitis B Surface Antigen After Stopping HBV Polymerase InhibitorsStefan Mauss
Journal of HIV Therapy|April 9, 2008
Clinical implications of resistance patterns against HBV-polymerase inhibitors for the treatment of chronic hepatitis BStefan Mauss
Journal of HIV Therapy|June 26, 2007
Management and therapy of chronic hepatitis C virus infection in HIV-infected individualsStefan Mauss
Zeitschrift Fur Gastroenterologie|January 17, 2015
[Prescription of new HCV-drugs - what has to be considered judicially]Stefan Mauss
MMW Fortschritte Der Medizin|November 26, 2008
[Treatment of chronic hepatitis B]Stefan Mauss
Alimentary Pharmacology & Therapeutics|December 28, 2023
Editorial: Tenofovir disoproxil fumarate, more than an antiviral drug-Another piece of the puzzleStefan Mauss
MMW Fortschritte Der Medizin|September 23, 2009
[Therapy of HIV-HBV-coinfection]Stefan Mauss
Journal of HIV Therapy|July 3, 2003
HIV-associated and antiretroviral-induced hyperlipidaemia: an updateStefan Mauss
Journal of Hepatology|December 17, 2005
Treatment of viral hepatitis in HIV-coinfected patients-adverse events and their managementStefan Mauss
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Drug-drug interactions in the treatment of HCV among people who inject drugsStefan Mauss, Hartwig Klinker
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Alimentary Pharmacology & Therapeutics|February 14, 2025
Editorial: The Relevance of Hepatic Flares and Quantitative Hepatitis B Surface Antigen After Stopping HBV Polymerase InhibitorsStefan Mauss
Journal of HIV Therapy|April 9, 2008
Clinical implications of resistance patterns against HBV-polymerase inhibitors for the treatment of chronic hepatitis BStefan Mauss
Journal of HIV Therapy|June 26, 2007
Management and therapy of chronic hepatitis C virus infection in HIV-infected individualsStefan Mauss
Zeitschrift Fur Gastroenterologie|January 17, 2015
[Prescription of new HCV-drugs - what has to be considered judicially]Stefan Mauss
MMW Fortschritte Der Medizin|November 26, 2008
[Treatment of chronic hepatitis B]Stefan Mauss
Alimentary Pharmacology & Therapeutics|December 28, 2023
Editorial: Tenofovir disoproxil fumarate, more than an antiviral drug-Another piece of the puzzleStefan Mauss
MMW Fortschritte Der Medizin|September 23, 2009
[Therapy of HIV-HBV-coinfection]Stefan Mauss
Journal of HIV Therapy|July 3, 2003
HIV-associated and antiretroviral-induced hyperlipidaemia: an updateStefan Mauss
Journal of Hepatology|December 17, 2005
Treatment of viral hepatitis in HIV-coinfected patients-adverse events and their managementStefan Mauss
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Drug-drug interactions in the treatment of HCV among people who inject drugsStefan Mauss, Hartwig Klinker
Pageof 16